A. Guerra-Ruiz

Bilirrubina: Medición y utilidad clínica en la enfermedad hepática

J. Crespo, P. Iruzubieta, Rosa Maria López Martínez, 2021, Advances in Laboratory Medicine.

Biochemical assessment of metabolic associated fatty liver disease

M. Morales-Ruiz, J. Crespo, P. Iruzubieta, 2021, Advances in laboratory medicine.

Valoración bioquímica en la enfermedad hepática grasa asociada a la disfunción metabólica

M. Morales-Ruiz, J. Crespo, P. Iruzubieta, 2021, Advances in Laboratory Medicine.

Increased bactericidal/permeability increasing protein in patients with cirrhosis

F. Pons‐Romero, Á. Estébanez, F. Casafont, 2010, Liver international : official journal of the International Association for the Study of the Liver.

Control of occult hepatitis B virus infection

X. Forns, S. Pérez‐del‐Pulgar, Gregori Casals Mercadal, 2022, Advances in laboratory medicine.

Endothelial dysfunction, measured by reactive hyperaemia using strain‐gauge plethysmography, is an independent predictor of adverse outcome in heart failure

Javier LLorca, J. Llorca, José R. Berrazueta, 2010, European journal of heart failure.

Influence of aquaporin-1 gene polymorphism on water retention in liver cirrhosis

E. Fábrega, F. Pons‐Romero, J. Rodríguez-Rey, 2011, Scandinavian journal of gastroenterology.